Q2 2019 Seres Therapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Second Quarter 2019 Seres Therapeutics Earnings Conference Call.
(Operator Instructions)
As a reminder, this conference is being recorded. I would like to introduce your host for today's conference, Mr. Carlo Tanzi, Vice President, Investor Relations. Sir, please go ahead.
Thank you, and good morning. Our press release with the company's second quarter 2019 financial results and a business update became available at 7 a.m. Eastern Time this morning and can be found on the Investors and Media section of the company's website.
I'd like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, regulatory matters, study designs, our development plans, our potential competitive advantages, the promise and potential impact of any of our microbiome therapeutics or clinical trial data and the sufficiency of our cash and cash equivalents
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
